Cargando…
Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida(®)) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms
The non-nucleoside reverse transcriptase inhibitor VM1500A is approved for the treatment of HIV/AIDS in its N-acyl sulphonamide prodrug form elsulfavirine (Elpida(®)). Biochemical profiling against twelve human carbonic anhydrase (CA, EC 4.2.1.1) isoforms showed that while elsulfavirine was a weak i...
Autores principales: | Supuran, Claudiu T., Nocentini, Alessio, Yakubova, Elena, Savchuk, Nikolay, Kalinin, Stanislav, Krasavin, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143618/ https://www.ncbi.nlm.nih.gov/pubmed/34000969 http://dx.doi.org/10.1080/14756366.2021.1927007 |
Ejemplares similares
-
7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
por: Pustenko, Aleksandrs, et al.
Publicado: (2020) -
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
por: Krasavin, Mikhail, et al.
Publicado: (2020) -
Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
por: Sharonova, Tatiana, et al.
Publicado: (2022) -
5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery
por: Kalinin, Stanislav, et al.
Publicado: (2022) -
Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
por: Kalinin, Stanislav, et al.
Publicado: (2021)